Current Genmab A/S forecasts and price targets in November 2026
Ø Analyst Price Targets
331.14 USD
-39.43 %
Median
343.83 USD
-37.11 %
Max
3,167.85 USD
Min
1,313.00 USD
Last Price
546.72 USD
Buy
16
Hold
8
Sell
2
The average target price for Genmab A/S is 331.14 USD. (-39.43 % below the current price)
The median price target of Genmab A/S is 343.83 USD.
Stock analysts from many renowned investment banks are closely examining the Genmab A/S stock. They conclude their professional Genmab A/S stock analyses with a clear recommendation for the Genmab A/S stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-04-01 | 17 | 8 | 2 | — |
| 2026-03-01 | 16 | 8 | 2 | 331.14 USD |
| 2026-02-01 | 16 | 8 | 2 | 340.63 USD |
| 2026-01-01 | 16 | 9 | 2 | 322.97 USD |
| 2025-12-01 | 17 | 8 | 2 | 318.05 USD |
| 2025-11-01 | 18 | 6 | 2 | 320.59 USD |
Genmab A/S Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Genmab A/S in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 4.49 B USD | 740.00 M USD | 11.00 USD |
| 2027e | 5.43 B USD | 1.10 B USD | 16.37 USD |
| 2028e | 6.93 B USD | 1.76 B USD | 26.17 USD |